I was puzzled that Absaroka would choose to go after a $2.50 stock with little or no stock borrow, and I am equally puzzled why the firm would use arguments that are so easily refutable. Some of the points raised clearly deserve attention and a detailed response by management, but the easily refuted points dilute the impact of the report. I have already sent the firm an email, and I hope to get a better understanding of our differences of opinion.Disclosure: The author holds no positions in any of the stocks mentioned. The author can be reached for comments at firstname.lastname@example.org.
Latest China Small-Cap Report Is Puzzling
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts